Making the diagnosis of nontuberculous mycobacteria (NTM) lung disease standard with the PREDICT study
Comparing how effective and safe 14 days and 28 days of inhaled aztreonam were at getting rid of a Pseudomonas bacterial lung infection.
STOP Codon mutations are associated with more severe disease from childhood in people with cystic fibrosis
Molecular fingerprinting of Pseudomonas aeruginosa from PWCF, and a UK reference laboratory investigation into frequency of cross-infection
Ivacaftor impacts nutrition and growth status in 4 to 24 month old children within the first 12 weeks